Literature DB >> 3349262

Radiation-induced outgrowth inhibition in explant cultures from surgical specimens of five human organs.

C Mothersill1, A Cusack, C B Seymour.   

Abstract

An explant outgrowth technique to determine the radiation response of five different human organs (bladder, oesophagus, colon, breast and thyroid) is described. In each case except thyroid, where malignancies are rare, data are presented for normal and malignant tissue. Results show that variations in response, consistent with those observed in vivo, can be measured. Tumours were in all cases highly resistant to radiation relative to their corresponding normal tissue. Possible reasons for this are discussed. The method may prove useful in the prediction of the radiobiological response for tumour and surrounding normal tissue where post-operative therapy is planned.

Entities:  

Mesh:

Year:  1988        PMID: 3349262     DOI: 10.1259/0007-1285-61-723-226

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Enhanced proliferation of cells from human tissue explants following irradiation in the presence of environmental carcinogens.

Authors:  C Mothersill; A Cusack; C B Seymour
Journal:  Radiat Environ Biophys       Date:  1989       Impact factor: 1.925

2.  The effect of radiation in combination with carcinogens on the growth of normal urothelium in explant culture.

Authors:  C Mothersill; A O'Brien; C B Seymour
Journal:  Radiat Environ Biophys       Date:  1990       Impact factor: 1.925

3.  Molecular and cellular features of esophageal cancer cells.

Authors:  T Nishihira; Y Hashimoto; M Katayama; S Mori; T Kuroki
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.

Authors:  C B Seymour; C Mothersill; R Mooney; M Moriarty; K F Tipton
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.